"DHR Health in Edinburg, Texas was originally opened as an outpatient facility in 1997 by a group of local doctors interested in providing personalized high quality healthcare to its patients. DHR has grown into a 500+ bed general acute care hospital, with a medical staff of over 700 physicians covering 75 specialties. Our MISSION is to improve the well-being of those we serve with a commitment to excellence: every patient, every encounter, every time. Serving the lower Rio Grande Valley, DHR Health sees patients from across Hidalgo County, including McAllen, Mission, and Pharr. We offer a wide range of services including emergency, stroke, and heart care."

During the past decade, Doctors Hospital at Renaissance conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 6 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Doctors Hospital at Renaissance" #1 sponsor was "Madrigal Pharmaceuticals, Inc." with 3 trials, followed by "Abbott Nutrition" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Sohail Rao" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Doctors Hospital at Renaissance" #1 collaborator was "DHR Health Institute for Research and Development" with 3 trials as a collaborator, "Wake Forest University Health Sciences" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Emory University" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Doctors Hospital at Renaissance" are "Cardiovascular Disease" (2 trials), "Non-Alcoholic Fatty Liver Disease" (2 trials), "Acute Ischemic Stroke" (1 trials), "Bleeding" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Doctors Hospital at Renaissance" in a lesser frequency.

Most popular intervention types in "Doctors Hospital at Renaissance" are "Drug" (11 trials), "Other" (4 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Experimental Infant Formula" (2 trials), "Resmetirom" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "Doctors Hospital at Renaissance" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Doctors Hospital at Renaissance". undefined are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Doctors Hospital at Renaissance, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Doctors Hospital at Renaissance, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".